Generic medicines are becoming increasingly important as a means of providing access to affordable healthcare by helping to suppress rising healthcare costs. This module aims to equip students with skills to assess the therapeutic equivalence of a generic medicinal product relative to a comparator, specifically with respect to bioavailability (BA) and bioequivalence (BE). Students will learn how to design and conduct appropriate bioavailability and bioequivalence studies in accordance with established international guidance documents, and to analyse the data from such studies.
Due to the limited availability of seats, early registration is strongly recommended.
Registration closes on 18 April 2020
Course Fee: SGD$3,611.25
Click here for a step by step guide on how to register.
Date and Time
13 Jul 2020 @ 09:00 - 17 Jul 2020 @ 18:00